EU OKs Novartis-Alcon Deal Following Sale Of Assets

By Melissa Lipman (August 10, 2010, 11:24 AM EDT) -- The European Commission has approved Novartis AG's bid to take over a majority stake in Alcon Laboratories Inc. based on Novartis' promise to sell off several ophthalmological drugs and consumer eye care products in the region, making the U.S. the last major jurisdiction that has yet to sign off on the deal....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!